1. Home
  2. A vs HLN Comparison

A vs HLN Comparison

Compare A & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agilent Technologies Inc.

A

Agilent Technologies Inc.

HOLD

Current Price

$129.42

Market Cap

39.8B

Sector

Industrials

ML Signal

HOLD

Logo Haleon plc (Each representing two)

HLN

Haleon plc (Each representing two)

HOLD

Current Price

$10.87

Market Cap

43.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
A
HLN
Founded
1999
2022
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Package Goods/Cosmetics
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
39.8B
43.7B
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
A
HLN
Price
$129.42
$10.87
Analyst Decision
Buy
Buy
Analyst Count
16
1
Target Price
$165.13
N/A
AVG Volume (30 Days)
1.9M
7.9M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.77%
1.68%
EPS Growth
3.16
41.64
EPS
4.57
0.23
Revenue
$6,948,000,000.00
$15,096,588,575.00
Revenue This Year
$8.00
$1.51
Revenue Next Year
$6.25
$4.67
P/E Ratio
$29.10
$47.13
Revenue Growth
6.73
N/A
52 Week Low
$96.43
$8.71
52 Week High
$160.27
$11.42

Technical Indicators

Market Signals
Indicator
A
HLN
Relative Strength Index (RSI) 33.91 71.79
Support Level $131.56 $10.28
Resistance Level $137.85 $10.57
Average True Range (ATR) 3.69 0.16
MACD -0.73 0.05
Stochastic Oscillator 2.25 94.22

Price Performance

Historical Comparison
A
HLN

About A Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: